Department of Pediatrics, Division of Critical Care, Wayne State University, Children's Hospital of Michigan, Detroit, Michigan, USA.
Ann Thorac Surg. 2013 Jun;95(6):2133-9. doi: 10.1016/j.athoracsur.2013.02.026. Epub 2013 Apr 18.
Children undergoing cardiac surgery may receive corticosteroids preoperatively to temper cardiopulmonary bypass-related inflammation, postoperatively for hemodynamic instability, and periextubation to reduce airway edema. Recent data have associated preoperative corticosteroids with infection. We aimed to determine if there is a relationship between cumulative corticosteroid exposure and infection.
A retrospective review of children who underwent cardiac surgery at our institution from January 2009 to July 2010 was performed. To limit study heterogeneity, patients who were 5 years or younger with basic Aristotle score of 7 or higher and intensive care unit stay of 7 days or more were included. Infections during the first 30 postoperative days were recorded, defined as clinically relevant positive blood, urine, respiratory, or wound cultures, or culture-negative sepsis treated with 7 or more days of antimicrobial therapy. Multivariate logistic regression analysis was performed to determine independent risk factors for infection.
Seventy-six patients were reviewed. All patients received intraoperative methylprednisolone, 48% received postoperative hydrocortisone, and 86% received periextubation dexamethasone. Twenty-six patients (36%) had 58 infections. On univariate analysis, patients with infection had greater median comprehensive Aristotle score (14.5 [intraquartile range (IQR): 12.5 to 16] versus 11.5 [IQR: 10 to 13.1], p = 0.001), maximum vasoactive inotrope score (29 [IQR: 24 to 40] versus 24 [IQR: 17 to 31], p = 0.031, days endotracheally intubated (12 [IQR: 7 to 30] versus 5 [IQR: 4 to 6.5], p < 0.001), and days of corticosteroid exposure (7 [IQR: 5 to 12] versus 4 [IQR: 2 to 5), p < 0.001). Also, patients with infections more often underwent delayed sternal closure (p = 0.008). On multivariate analysis, days endotracheally intubated (p = 0.023) and days of corticosteroid exposure (p = 0.015) remained significant.
For children undergoing complex cardiac surgery, greater cumulative duration of corticosteroid exposure is independently associated with postoperative infection.
接受心脏手术的儿童可能会在术前接受皮质类固醇以缓解体外循环相关炎症,术后接受皮质类固醇以稳定血液动力学,并在拔管前后使用皮质类固醇以减轻气道水肿。最近的数据表明,术前使用皮质类固醇与感染有关。我们旨在确定皮质类固醇累积暴露量与感染之间是否存在关系。
对我院 2009 年 1 月至 2010 年 7 月期间接受心脏手术的儿童进行回顾性研究。为了限制研究的异质性,纳入了基本 Aristotle 评分≥7 且 ICU 住院时间≥7 天且年龄≤5 岁的患者。记录术后 30 天内的感染情况,感染定义为临床相关的阳性血、尿、呼吸或伤口培养物,或使用 7 天以上抗生素治疗的培养阴性败血症。采用多变量逻辑回归分析确定感染的独立危险因素。
共回顾了 76 例患者。所有患者均接受术中甲泼尼龙治疗,48%的患者接受术后氢化可的松治疗,86%的患者接受拔管前后地塞米松治疗。26 例(36%)患者发生 58 例感染。单因素分析显示,感染患者的中位数综合 Aristotle 评分较高(14.5 [四分位距(IQR):12.5 至 16] 与 11.5 [IQR:10 至 13.1],p=0.001),最大血管活性儿茶酚胺评分较高(29 [IQR:24 至 40] 与 24 [IQR:17 至 31],p=0.031),气管插管时间较长(12 [IQR:7 至 30] 与 5 [IQR:4 至 6.5],p<0.001),皮质类固醇暴露时间较长(7 [IQR:5 至 12] 与 4 [IQR:2 至 5],p<0.001)。此外,感染患者更常发生延迟胸骨闭合(p=0.008)。多因素分析显示,气管插管时间(p=0.023)和皮质类固醇暴露时间(p=0.015)仍然具有统计学意义。
对于接受复杂心脏手术的儿童,皮质类固醇累积暴露时间越长,术后感染的风险越高。